4.7 Article

Apomorphine Treatment in Alzheimer Mice Promoting Amyloid-β Degradation

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?

Marwan N. Sabbagh

AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2009)

Review Behavioral Sciences

Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

Dennis J. Selkoe

BEHAVIOURAL BRAIN RESEARCH (2008)

Article Clinical Neurology

Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimer's Disease

Y. Ohyagi

CURRENT ALZHEIMER RESEARCH (2008)

Review Cell Biology

The ubiquitin-proteasome system in Alzheimer's disease

Salvatore Oddo

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)

Article Geriatrics & Gerontology

Aβ inhibits the proteasome and enhances amyloid and tau accumulation

Bertrand P. Tseng et al.

NEUROBIOLOGY OF AGING (2008)

Review Clinical Neurology

Apomorphine for the acute treatment of off episodes in Parkinson's disease

Mark Stacy et al.

PARKINSONISM & RELATED DISORDERS (2008)

Review Neurosciences

Intracellular amyloid-β in Alzheimer's disease

Frank M. LaFerla et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Article Biochemical Research Methods

Intraneuronal amyloid β42 enhanced by heating but counteracted by formic acid

Yasumasa Ohyagi et al.

JOURNAL OF NEUROSCIENCE METHODS (2007)

Article Biochemistry & Molecular Biology

Reduction of soluble Aβ and Tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

Salvatore Oddo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Neurosciences

Neuroprotection in Parkinson models varies with toxin administration protocol

David W. Anderson et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2006)

Review Chemistry, Medicinal

Intracellular amyloid β-protein and its associated molecules in the pathogenesis of Alzheimer's disease

Yasumasa Ohyagi et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)

Article Pharmacology & Pharmacy

Protection by apomorphine in two independent models of acute inhibition of oxidative metabolism in rodents

P Castri et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2006)

Article Pathology

A dynamic relationship between intracellular and extracellular pools of A beta

S Oddo et al.

AMERICAN JOURNAL OF PATHOLOGY (2006)

Review Biotechnology & Applied Microbiology

beta-amyloid degradation and Alzheimer's disease

Deng-Shun Wang et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)

Review Geriatrics & Gerontology

Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease

GK Gouras et al.

NEUROBIOLOGY OF AGING (2005)

Article Pharmacology & Pharmacy

Central mechanisms regulating penile erection in conscious rats: The dopaminergic systems related to the proerectile effect of apomorphine

GC Hsieh et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)

Article Biochemistry & Molecular Biology

Iron and alpha-synuclein in the substantia nigra of MPTP-treated Mice

S Mandel et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2004)

Article Neurosciences

Relationship between β-amyloid degradation and the 26S proteasome in neural cells

ML Salon et al.

EXPERIMENTAL NEUROLOGY (2003)

Article Neurosciences

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

A Gómez-Ramos et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2003)

Article Biochemistry & Molecular Biology

New class of inhibitors of amyloid-β fibril formation -: Implications for the mechanism of pathogenesis in Alzheimer's disease

HA Lashuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

E Grünblatt et al.

JOURNAL OF NEUROCHEMISTRY (2001)